Potensi Bunga Telang (Clitoria ternatea L.) terhadap Sindrom Metabolik

Ni Luh Desy Rupadani, Desak Ketut Ernawati, I.G.M.G. Surya Candra Trapika

Abstract


Sedentary lifestyle such as consuming fast food, fatty foods, smoking and rarely doing physical activity are triggers for metabolic syndrome. Metabolic syndrome is a collection of risk factors for metabolic and cardiovascular disease consisting of dyslipidemia, obesity, hypertension and insulin resistance. The presence of metabolic syndrome will lead to a doubled risk of cardiovascular disease compared to patients without metabolic syndrome. Cardiovascular disease is the leading cause of death worldwide. One of the plants that has benefits for preventing and treating metabolic syndrome is telang (Clitoria ternatea L.). Almost all parts of the telang plant can be used for preventive and medicinal therapies, but the most commonly used part of the plant is the flower. Telang flowers are known to have antiobesity, antidiabetic, antioxidant and other activities. Telang flowers have chemical compound components in the form of flavonoids, alkaloids, tannins, saponins, phenolic acids and terpenoids.

Keywords


Metabolic syndrome, Telang flower (Clitoria ternatea L.)

Full Text:

PDF

References


Mohamed, S.M., Shalaby, M.A., El-Shiekh, R.A., El-Banna, H.A., Eman, S.R., dan Bakr, A.F. 2023. Metabolic syndrome : risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chemistry Advances. 3(2023): 1-14.

Saklayen, M. G. 2018. The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20(2), 12. 10.1007/s11906-018-0812-z.

Beltrán-Sánchez, H., Harhay, M. O., Harhay, M. M., & McElligott, S. 2013. Prevalence and trends of metabolic syndrome in the adult US population, 1999–2010. Journal of the American College of Cardiology, 62(8), 697–703. 10.1016/j.jacc.2013.05.064.

Rochlani, Y., Pothineni, N. V., Kovelamudi, S., & Mehta, J. L. 2017. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Therapeutic Advances in Cardiovascular Disease, 11(8), 215–225.

Delavari, A., Forouzanfar, M. H., Alikhani, S., Sharifian, A., & &Kelishadi, R 2009. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care, 32(6), 1092–1097. 10.2337/dc08-1800.

Lillich, F. F., Imig, J. D., & Proschak, E. 2021. Multi-target approaches in metabolic syndrome. Frontiers in Pharmacology, 11, Article 554961.

Min, J., Chiu, D. T., & Wang, Y. 2013. Variation in the heritability of body mass index based on diverse twin studies: a systematic review. Obesity Reviews, 14(11), 871–882.

Aron Wisnewsky, J., & Clément, K. 2016. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nature Reviews Nephrology, 12(3), 169–181. 10.1038/nrneph.2015.191.

Rizzo, N. S., Sabaté, J., Jaceldo-Siegl, K., & Fraser, G. E. 2011. Vegetarian dietary patterns are associated with a lower risk of metabolic syndrome: the adventist health study 2. Diabetes Care, 34(5), 1225–1227.

Erion, D. M., & Shulman, G. I. 2010. Diacylglycerol mediated insulin resistance. Nature Medicine, 16(4), 400–402. 10.1038/nm0410-400.

Kagawa, Y., Nishijima, C., Nakayama, K., Iwamoto, S., Tanaka, A., Kamachi, K., & Kawabata, T. 2016. Nutrigenetics of Japanese Vegetarians with Polymorphism in the Fatty Acid Desaturase. Journal of Nutrition and Food Sciences, 6, 1–15. 10.4172/2155-9600.1000498.

Grundy, S. M. 2016. Metabolic syndrome update. Trends in Cardiovascular Medicine, 26(4), 364–373. 10.1016/j.tcm.2015.10.004.

Dunstan, D. W., Barr, E. L., Healy, G., Salmon, J., Shaw, J., Balkau, B., Magliano, D. J., Cameron, A. J., Zimmet, P. Z., & Owen, N. 2010. Television viewing time and mortal- ity: the Australian diabetes, obesity and lifestyle study (AusDiab). Circulation, 121(3), 384–391. 10.1161/CIRCULATIONAHA.109.894824.

Thorp, A. A., Healy, G. N., Owen, N., Salmon, J., Ball, K., Shaw, J. E., Zimmet, P. Z., & Dunstan, D. W. 2010. Deleterious associations of sitting time and television viewing time with cardiometabolic risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004–2005. Diabetes Care, 33(2), 327–334.

Tran, V. D., James, A. P., Lee, A. H., Jancey, J., Howat, P. A., & Thi Phuong Mai, L. 2017. Effectiveness of a community-based physical activity and nutrition behavior intervention on features of the metabolic syndrome: a cluster-randomized controlled trial. Metabolic Syndrome and Related Disorders, 15(2), 63–71. 10.1089/met.2016.0113.

Yan Namen, M., Prendergast, L., & Peiris, C. 2019. Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: a systematic review and meta analysis. Metabolism, 101, Article 153988. 10.1016/j.metabol.2019.153988.

Cena, H., Fonte, M. L., & Turconi, G. 2011. Relationship between smoking and metabolic syndrome. Nutrition Reviews, 69(12), 745–753. 10.1111/j.1753-4887.2011.00446.x.

Pyykkönen, A.-J., Räikkönen, K., Tuomi, T., Eriksson, J. G., Groop, L., & Isomaa, B. 2010. Stressful life events and the metabolic syndrome: the prevalence, prediction and pre- vention of diabetes (PPP)-Botnia Study. Diabetes Care, 33(2), 378–384.

Wu, P. W., Lai, Y. W., Chin, Y. T., Tsai, S., Yang, T. M., Lin, W. T., Lee, C. Y., Tsai, W. C., Huang, H. L., Seal, D. W., Duh, T. H., & Seal, D. W. 2022. Stability and transformation of metabolic syndrome in adolescents: A prospective assessment in relation to the change of cardiometabolic risk factors. Nutrients, 14(4), 744. 10.3390/nu14040744.

Hassan, M. M. M., Abdelkreem, M. I., Mahmoud, H. E. M., & Mohammed, A. M. 2022. Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Knee Osteoarthritis. SVU-International Journal of Medical Sciences, 5(1), 343–349. 10.21608/SVUIJM.2022.118452.1269.

Sacramento, J. F., Ribeiro, M. J., Rodrigues, T., Olea, E., Melo, B. F., Guarino, M. P., Ferreira, C. R., Coelho, J., Obeso, A., Seiça, R., Matafome, P., & Conde, S. V. 2017. Functional abolition of carotid body activity restores insulin action and glucose home- ostasis in rats: key roles for visceral adipose tissue and the liver. Diabetologia, 60(1), 158–168. 10.1007/s00125-016-4133-y.

Ehrampoush, E., Homayounfar, R., Davoodi, S. H., Zand, H., Askari, A., & Kouh- payeh, S. A. 2016. Ability of dairy fat in inducing metabolic syndrome in rats. SpringerPlus, 5(1). 10.1186/s40064-016-3716-x.

Zhou, M. S., Schulman, I. H., & Zeng, Q. 2012. Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease. Vascular Medicine, 17(5), 330–341. 10.1177/1358863×12450094.

Monserrat M, M., Quetglas-Llabrés, M., Capó, X., Bouzas, C., Mateos, D., Pons, A., Bouzas, C., Mateos, D., Pons, A. A., Tur, J., & Sureda, A 2020. Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants, 9(3), 236.

Sladoje, D. P., Kisić, B., & Mirić, D. 2017. The monitoring of protein markers of inflammation and serum lipid concentration in obese subjects with metabolic syndrome. Journal of Medical Biochemistry, 36(4), 366.

Sheikhansari, G., Soltani-Zangbar, M. S., Pourmoghadam, Z., Kamrani, A., Azizi, R., AghebatiMaleki, L., Danaii, S., Koushaeian, L., Hojat-Farsangi, M., & Yousefi, M. 2019. Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent im- plantation failure patients with metabolic syndrome. American Journal of Reproductive Immunology, 82(4), e13170.

Oda, E. 2018. Historical perspectives of the metabolic syndrome. Clinics in Dermatology, 36(1), 3–8.

Cai, Z., Huang, Y., & He, B. 2022. New Insights into Adipose Tissue Macrophages in Obesity and Insulin Resistance. Cells, 11(9), 1424. 10.3390/cells11091424.

Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. 2014. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature, 510(7503), 84–91.

Gangireddy, V. G. R., Pilkerton, C., Xiang, J., Tinajero, R., & Ashcraft, A. M. 2022. Hep- atic fibrosis and steatosis in metabolic syndrome. Journal of Obesity & Metabolic Syndrome, 31(1), 61. 10.7570/jomes2

Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. 2011. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology, 11(2), 85–97. 10.1038/nri2921.

Lim, S., & Eckel, R. H. 2014. Pharmacological treatment and therapeutic perspectives of metabolic syndrome. Reviews in Endocrine and Metabolic Disorders, 15(4), 329–341. 10.1007/s11154-014-9298-4.

Mendonca, F. M., de Sousa, F. R., Barbosa, A. L., Martins, S. C., Araujo, R. L., Soares, R., & Abreu, C. 2015. Metabolic syndrome and risk of cancer: Metabolism, 64(2), 182–189. 10.1016/j.metabol.2014.10.008.

Cohen, D. H., & LeRoith, D. 2012. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocrine-Related Cancer, 19(5), F27–F45. 10.1530/ERC-11-0374.

Maury, E., & Brichard, S. M. 2010. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology, 314(1), 1–16. 10.1016/j.mce.2009.07.031.




DOI: https://doi.org/10.34008/jurhesti.v9i1.324

Article Metrics

Abstract view : 0 times
PDF View - 0 times

Refbacks

  • There are currently no refbacks.


Lisensi Creative Commons

This work is licensed under a Creative Commons Attribution 4.0 International License